About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Biomarker Helps Predict Patient's Response to Diabetic Complication

by Hannah Joy on March 12, 2018 at 1:19 PM
Font : A-A+

New Biomarker Helps Predict Patient's Response to Diabetic Complication

A novel biomarker was identified from fluid in the eye that helps predict which patient can best respond to current treatments for diabetic macular edema, reveals a new study,

Diabetic macular edema is one of the most common complications of diabetes . It is the accumulation of fluid in the macula, an area in the center of the retina responsible for sharp, straight-ahead vision.

Advertisement


The fluid buildup causes the macula to swell and thicken, which blurs vision. Dr. Muni said it is the leading cause of vision loss in people under the age of 65 in North America.

Their study, led by Dr. Rajeev Muni, a vitreoretinal surgeon at St. Michael's hospital, was published online in the journal JAMA Ophthalmology.
Advertisement

Treatment for diabetic macular edema has evolved dramatically in the last decade, but still requires a sometimes painful injection in the eye, in some cases as often as once a month.

Dr. Muni said that while this treatment has been a "game-changer," preserving and even restoring vision in people who might otherwise have gone blind, some people respond to it better than others.

In his study, he took fluid samples from the front, or anterior, chamber of the eyes of 48 patients who were then treated with a ranibizumab injection (tradename Lucentis).

They found there were two molecules that were associated with who responded better to the injections than others.

The first, which was somewhat expected, was low levels of vascular endothelial growth factor, or VEGF, a protein produced in the eye when there is poor blood flow.

Ranibizumab is known to bind to VEGF, reducing the amount of VEGF in the eye, meaning there is less leakage from blood vessels and less fluid accumulation.

But Dr. Muni said the biggest predictor of who will respond to treatment was high levels of a different molecule, ICAM-1, one of a group of molecules known as cytokines that both help cells communicate immune responses and stimulate the movement of cells toward sites of inflammation.

"Now we have a novel biomarker to determine who will respond best to treatment," said Dr. Muni.

"The prospect of ongoing injections in the eye is daunting for patients. The fact that we can now measure a protein in the eye that allows us to predict which patients are less likely respond to treatment, could lead to more personalized and tailored medicine and fewer injections. This could alleviate the treatment burden on patients and the health-care system."

He said St. Michael's was enrolling people for a bigger followup trial to determine the optimal interval between injection treatments based on the levels of these biomarkers.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
January is the Thyroid Awareness Month in 2022
Menstrual Disorders
Coffee May Help You Fight Endometrial Cancer
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Diabetes - Self-Monitoring of Blood Glucose (SMBG) Diabetes and Exercise Pregnancy and Complications Glycemic Index Type 2 Diabetes Decoding HbA1c Test for Blood Sugar Diabetes - Foot Care Diet Guidelines for Healthy Snacking Diabetic Kidney Disease Diabetes in Pets 

Recommended Reading
2-Year Outcomes of Diabetic Macular Edema Treatment Reported in New Study
The greater efficacy of bevacizumab compared with macular laser therapy was demonstrated in a ......
Increase in Risk For Diabetic Macular Edema Due To Thiazolidinedione Use In Patients With Type 2 Diabetes
According to a report treatment with glucose-lowering thiazolidinedione drugs in patients with Type ...
NICE Rejects Lucentis for Diabetic Macular Edema
Leading drug maker Novartis received a major blow on Friday after the British health agency ......
Study Explores Prevalence, Risk Factors for Diabetic Macular Edema
Racial differences are seen in the prevalence of diabetic macular edema and among individuals ......
Decoding HbA1c Test for Blood Sugar
The HbA1c assay is the gold-standard measurement of chronic glycemia and measures the amount of gluc...
Diabetes - Foot Care
Valuable information on diabetic foot care, treatment and prevention....
Diabetes - Self-Monitoring of Blood Glucose (SMBG)
Self-Monitoring Of Blood Glucose (SMBG) is one of the greatest advancements in the management of Di...
Diabetes and Exercise
Regular exercise especially in type II diabetes not only helps reduce the sugar but also reduces the...
Diabetes in Pets
Pets like cats and dogs suffer from diabetes, which is similar to that in humans. It is treated with...
Diabetic Kidney Disease
Diabetic nephropathy refers to kidney damage due very high levels of blood sugar levels in diabeti...
Diet Guidelines for Healthy Snacking
Due to busy lifestyles, food holds the least amount of importance for many of us. Healthy snacking i...
Glycemic Index
GLYCEMIC INDEX (GI) is a scale which helps to rank carbohydrate- rich foods, depending on how they a...
Pregnancy and Complications
In-depth guide for expecting mothers to overcome health complications related to early or late pregn...
Type 2 Diabetes
Globalization and changing lifestyles has made diabetes very common in developing countries so much ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
ASK A DOCTOR ONLINE
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)